NovaBridge Biosciences (NBP) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.14M | 1.17M | 9.83M | 9.83M |
| Revenue Growth % | - | - | - | - | -100% | -100% | -100% | -100% | -99.8% | 100.85% | -62.1% | -62.1% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.16M | 1.17M | 9.83M | 9.83M |
| Gross Margin % | - | - | - | - | - | - | - | - | -1687.47% | 100% | 100% | 100% |
| Gross Profit Growth % | - | - | - | - | 100% | -100% | -100% | -100% | 85.98% | 100.85% | -20.17% | -20.17% |
| Operating Expenses | 10.42M | 8.99M | 7.11M | 5.27M | 13.37M | 12.41M | 258.95M | 90.62M | 176M | 181.04M | 345.71M | 345.71M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | 15498.08% | 15498.06% | 3517.82% | 3517.82% |
| Selling, General & Admin | 2.46M | 5.81M | 3.82M | 4.49M | 7.34M | 7.94M | 149.51M | 51.67M | -285.1M | 5.86M | 122.5M | 122.5M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | -25104.27% | 501.73% | 1246.46% | 1246.46% |
| Research & Development | 7.96M | 3.18M | 3.29M | 777K | 6.03M | 4.47M | 109.44M | 38.95M | 101.07M | 5.09M | 223.22M | 223.22M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | 8900.04% | 435.56% | 2271.36% | 2271.36% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 0 | 0 |
| Operating Income | -10.42M | -8.99M | -7.11M | -5.27M | -13.37M | -12.41M | -17.14M | -90.62M | -174.87M | 335.48M | -335.89M | -335.89M |
| Operating Margin % | - | - | - | - | - | - | - | - | -15398.08% | 28718.5% | -3417.82% | -3417.82% |
| Operating Income Growth % | 22.06% | 27.58% | 58.49% | 94.19% | 92.35% | -103.7% | 94.9% | 73.02% | -117% | -67.39% | -128.15% | -128.15% |
| EBITDA | -10.39M | -8.77M | -6.99M | -4.79M | -13.16M | -6.42M | -11.15M | -84.63M | -168.88M | 341.81M | 0 | 0 |
| EBITDA Margin % | - | - | - | - | - | - | - | - | -14870.87% | 29260.8% | - | - |
| EBITDA Growth % | 21.03% | -36.61% | 37.37% | 94.34% | 92.21% | -101.88% | - | - | -116.31% | -66.97% | -100% | -100% |
| D&A (Non-Cash Add-back) | 30.88K | 216K | 128.95K | 473.71K | 213K | 5.99M | 5.99M | 5.99M | 5.99M | 6.33M | 335.89M | 335.89M |
| EBIT | -10.42M | -8.99M | -7.11M | -5.27M | -12.1M | -12.41M | -124.56M | -90.62M | -282.12M | -10.63M | -12.05M | -335.89M |
| Net Interest Income | 256.18K | 2.15M | 1.8M | 1.87M | 2.2M | 2.45M | 1.92M | 709K | 209.46K | 10.37M | -18.52M | 15.15M |
| Interest Income | 256.18K | 2.15M | 1.8M | 1.87M | 2.2M | 2.45M | 1.92M | 709K | 311.31K | 10.37M | -18.52M | 15.15M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 6K | 2.16M | 1.61M | 15.36M | 2.53M | -8.08M | -34.48M | 20.64M | -61.99M | -791.52M | -50.51M | -50.51M |
| Pretax Income | -10.42M | -6.83M | -5.5M | -3.15M | -10.84M | -20.49M | -49.49M | -69.98M | -236.86M | -456.04M | -386.4M | -386.4M |
| Pretax Margin % | - | - | - | - | - | - | - | - | -20856.81% | -39039% | -3931.8% | -3931.8% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | -42.68M | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 86.24% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -4.4M | -6.83M | -5.5M | -3.15M | -9.06M | -20.49M | 25.13M | 20.84M | -346.45M | -346.45M | -386.4M | -386.4M |
| Net Margin % | - | - | - | - | - | - | - | - | -30506.72% | -29657.67% | -3931.8% | -3931.8% |
| Net Income Growth % | 51.43% | 66.68% | -121.91% | -115.11% | 97.38% | 94.09% | 106.5% | 105.39% | 52.56% | 52.56% | 26.18% | 26.18% |
| Net Income (Continuing) | -10.42M | -6.83M | -5.5M | -3.15M | -10.84M | -20.49M | -8.94M | -69.98M | -346.45M | -8.22M | -386.4M | -386.4M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 1000K | 0 | 1000K | 1000K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.09 | -0.16 | -0.07 | -0.28 | -0.11 | -0.25 | 0.30 | -0.85 | -4.16 | -4.16 | -0.74 | -4.65 |
| EPS Growth % | 19.27% | 36% | -122.53% | 67.06% | 97.36% | 93.99% | 140.54% | 81.72% | 52.78% | 52.78% | 88.38% | 27% |
| EPS (Basic) | -0.09 | -0.16 | -0.07 | -0.28 | -0.11 | -0.25 | 0.30 | -0.21 | -4.16 | -4.16 | -0.74 | -4.65 |
| Diluted Shares Outstanding | 50.17M | 43.89M | 81.7M | 81.6M | 81.5M | 81.5M | 80.93M | 80.87M | 83.29M | 83.29M | 83.17M | 83.17M |
| Basic Shares Outstanding | 50.17M | 43.89M | 81.7M | 81.6M | 81.5M | 81.5M | 81.78M | 82.06M | 83.21M | 83.21M | 83.17M | 83.17M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |